Extremely low birth weight infants (birth weight ≤1000 g) have a significantly lower nephron number. The glomerular filtration rate (GFR) is usually sufficient under normal conditions but is unable to meet the needs during stress, which results in acute kidney injury (AKI). We describe the case of an extremely low birth weight infant (970 g) with a gestational age of 27 weeks (immature preterm) who was mechanically ventilated because of hyaline membrane disease. AKI with anuria and a rise in serum creatinine to 3.4 mg/dL developed in the second week. Diuresis was restored after diuretics and dopamine were administered intravenously and kidney function recovered in the next two weeks. However, he slowly became hypertensive, so intravenous enalapril was introduced in the 6th week. After the third dose, he suffered another AKI. After cessation of enalapril, kidney function recovered over the next few days. Although angiotensin-converting enzyme inhibitors (ACEi) may cause kidney injury, it can be used with great caution in the treatment of hypertension or heart failure in preterm infants. There remains a real dilemma of whether enalapril should be used in extremely low birth weight immature infants.
Skip Nav Destination
Article navigation
CLINICAL VIGNETTE|
August 16 2021
Enalapril and Acute Kidney Injury in a Hypertensive Premature Newborn – Should It Be Used or Not?
Zlatka Kanic, MD, PhD;
Correspondence. Zlatka Kanic; zlatka.kanic@guest.arnes.si
Search for other works by this author on:
The Journal of Pediatric Pharmacology and Therapeutics (2021) 26 (6): 638–642.
Article history
Received:
November 22 2020
Accepted:
December 28 2020
Citation
Zlatka Kanic, Vojko Kanic, Tina Hojnik; Enalapril and Acute Kidney Injury in a Hypertensive Premature Newborn – Should It Be Used or Not?. The Journal of Pediatric Pharmacology and Therapeutics 1 September 2021; 26 (6): 638–642. doi: https://doi.org/10.5863/1551-6776-26.6.638
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionGet Email Alerts
Citing articles via
Comparison of Two Lipid Emulsions on the Incidence of Parenteral Nutrition Associated Cholestasis in Neonates
Joy Greenberg, PharmD<span class='al-author-delim'>, </span>Mamta Naik, RD, PharmD<span class='al-author-delim'>, </span>John Chapman, MD<span class='al-author-delim'>, </span>Allison Davidson, DO<span class='al-author-delim'>, </span>Essam Imseis, MD
Effect of a Pharmacist-Led Discharge Counseling Service at a Children's Hospital
Sara W. Hovey, PharmD<span class='al-author-delim'>, </span>Milica Misic, PharmD<span class='al-author-delim'>, </span>Jessica L. Jacobson, PharmD<span class='al-author-delim'>, </span>Kristen W. Click, PharmD
Low-Dose TMP-SMX for Pneumocystis jirovecii Pneumonia Prophylaxis in Pediatric Solid Organ Transplant Recipients
Justin K. Chen, PharmD<span class='al-author-delim'>, </span>Jack Guerci, PharmD<span class='al-author-delim'>, </span>Heather Corbo, PharmD<span class='al-author-delim'>, </span>Marc Richmond, MD<span class='al-author-delim'>, </span>Mercedes Martinez, MD
Methylnaltrexone for Opioid-Induced Dysmotility in Critically Ill Infants and Children: A Pilot Study
Christina J. Smith, PharmD<span class='al-author-delim'>, </span>Caroline M. Sierra, PharmD<span class='al-author-delim'>, </span>Joanna Robbins, PharmD<span class='al-author-delim'>, </span>Nancy Y. Chang, PharmD<span class='al-author-delim'>, </span>Farrukh Mirza, MD
Implementation of a Shared Pediatric Pharmacy Elective During the COVID-19 Pandemic
Emily N. Israel, PharmD<span class='al-author-delim'>, </span>Chad A. Knoderer, PharmD